Immunome, Inc. (IMNM)
NASDAQ
Market Cap
$721.43M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
90 of 809
Rank in Industry
69 of 445
Largest Insider Buys in Sector
IMNM Stock Price History Chart
IMNM Stock Performance
About Immunome, Inc.
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Insider Activity of Immunome, Inc.
Over the last 12 months, insiders at Immunome, Inc. have bought $2.67M and sold $0 worth of Immunome, Inc. stock.
On average, over the past 5 years, insiders at Immunome, Inc. have bought $2.21M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SIEGALL CLAY B (President and CEO) — $4.78M. Turner Bruce (Chief Strategy Officer) — $249,993. BIENAIME JEAN JACQUES (director) — $108,559.
The last purchase of 20,434 shares for transaction amount of $281,548 was made by SIEGALL CLAY B (President and CEO) on 2024‑05‑21.
List of Insider Buy and Sell Transactions, Immunome, Inc.
| 2024-05-21 | SIEGALL CLAY B | President and CEO | 20,434 0.0344% | $13.78 | $281,548 | +7.18% | ||
| 2024-05-21 | BIENAIME JEAN JACQUES | director | 2,000 0.0033% | $13.57 | $27,140 | +7.18% | ||
| 2024-05-20 | SIEGALL CLAY B | President and CEO | 79,566 0.1337% | $13.91 | $1.11M | +5.60% | ||
| 2023-10-02 | SIEGALL CLAY B | President and CEO | 169,204 0.9994% | $5.91 | $999,996 | +74.88% | ||
| 2023-10-02 | Turner Bruce | Chief Strategy Officer | 42,300 0.2498% | $5.91 | $249,993 | +74.88% | ||
| 2021-09-13 | RAPP MICHAEL | director | 25,962 0.2086% | $19.96 | $518,202 | -72.24% | ||
| 2021-09-10 | RAPP MICHAEL | director | 15,500 0.1243% | $17.85 | $276,675 | -68.95% | ||
| 2021-09-09 | RAPP MICHAEL | director | 30,450 0.2559% | $18.19 | $553,774 | -67.84% | ||
| 2021-05-26 | RAPP MICHAEL | director | 2,300 0.0194% | $18.94 | $43,562 | -22.31% | ||
| 2021-05-26 | Lefenfeld Michael | director | 1,335 0.0113% | $19.03 | $25,405 | -22.31% | ||
| 2021-05-25 | RAPP MICHAEL | director | 19,303 0.167% | $18.32 | $353,631 | -17.32% | ||
| 2021-05-25 | Lefenfeld Michael | director | 2,715 0.0236% | $18.44 | $50,065 | -17.32% | ||
| 2021-05-25 | Sarma Purnanand D | President and CEO | 10,500 0.0913% | $18.41 | $193,305 | -17.32% | ||
| 2021-05-24 | WAGENHEIM PHILIP | director | 13,500 0.1182% | $18.35 | $247,725 | -16.23% | ||
| 2021-05-24 | RAPP MICHAEL | director | 31,895 0.2796% | $18.38 | $586,230 | -16.23% | ||
| 2021-05-24 | LAMATTINA JOHN L | director | 5,440 0.0482% | $18.57 | $101,028 | -16.23% | ||
| 2021-05-24 | Lefenfeld Michael | director | 600 0.0051% | $17.80 | $10,680 | -16.23% | ||
| 2020-10-06 | RAPP MICHAEL | director | 83,332 2.2282% | $12.00 | $999,984 | +27.45% |
Insider Historical Profitability
<0.0001%
| SIEGALL CLAY B | President and CEO | 419636 0.748% | $12.03 | 3 | 0 | |
| Turner Bruce | Chief Strategy Officer | 42300 0.099% | $12.03 | 1 | 0 | |
| BIENAIME JEAN JACQUES | director | 9615 0.016% | $12.03 | 1 | 0 | |
| WAGENHEIM PHILIP | director | 397397 0.93% | $12.03 | 1 | 0 | <0.0001% |
| RAPP MICHAEL | director | 208742 0.4885% | $12.03 | 7 | 0 | <0.0001% |
| LAMATTINA JOHN L | director | 51828 0.1213% | $12.03 | 1 | 0 | <0.0001% |
| Lefenfeld Michael | director | 26872 0.0629% | $12.03 | 3 | 0 | <0.0001% |
| Sarma Purnanand D | President and CEO | 10500 0.0246% | $12.03 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Redmile Group | $120.67M | 8.15 | 4.89M | +26.04% | +$24.93M | 4.47 | |
| Fidelity Investments | $111.91M | 7.56 | 4.53M | +16.09% | +$15.51M | 0.01 | |
| Ecor1 Capital Llc | $95.74M | 6.47 | 3.88M | 0% | +$0 | 2.43 | |
| T. Rowe Price | $55.42M | 3.75 | 2.25M | +113.63% | +$29.48M | 0.01 | |
| The Vanguard Group | $49.85M | 3.37 | 2.02M | +16.07% | +$6.9M | <0.01 | |
| Point72 Asset Management | $40.52M | 2.74 | 1.64M | +140.53% | +$23.68M | 0.08 | |
| Janus Henderson | $37.96M | 2.57 | 1.54M | +10.56% | +$3.63M | 0.02 | |
| T Rowe Price Investment Management Inc | $37.43M | 2.53 | 1.52M | New | +$37.43M | 0.02 | |
| Woodline Partners LP | $32.53M | 2.2 | 1.32M | +42.82% | +$9.75M | 0.31 | |
| Avidity Partners Management Lp | $21.57M | 1.46 | 873,891 | -34.47% | -$11.34M | 0.78 | |
| BlackRock | $20.46M | 1.38 | 829,013 | +112.22% | +$10.82M | <0.0001 | |
| Tang Capital Management, LLC | $17.77M | 1.2 | 720,000 | New | +$17.77M | 0.07 | |
| Brown Advisory | $16.53M | 1.12 | 669,760 | New | +$16.53M | 0.02 | |
| Invesco | $15.43M | 1.04 | 625,083 | New | +$15.43M | <0.01 | |
| Sofinnova | $14.67M | 0.99 | 594,396 | New | +$14.67M | 0.03 | |
| Farallon Capital | $14.66M | 0.99 | 594,000 | New | +$14.66M | 0.1 | |
| Qube Research & Technologies | $13.09M | 0.89 | 530,462 | +160.61% | +$8.07M | 0.02 | |
| Marshall Wace | $12.87M | 0.87 | 521,551 | New | +$12.87M | 0.02 | |
| Millennium Management LLC | $11.48M | 0.78 | 465,286 | +1,191.82% | +$10.59M | 0.01 | |
| Lord Abbett | $10.99M | 0.74 | 445,435 | New | +$10.99M | 0.04 | |
| Geode Capital Management | $10.68M | 0.72 | 432,479 | +34.8% | +$2.76M | <0.01 | |
| Victory Capital Management Inc | $8.76M | 0.59 | 354,762 | New | +$8.76M | 0.01 | |
| Goldman Sachs | $8.19M | 0.55 | 331,764 | New | +$8.19M | <0.01 | |
| Susquehanna International Group | $7.89M | 0.53 | 319,514 | +817.43% | +$7.03M | 0.01 | |
| Atika Capital Management Llc | $7.77M | 0.53 | 315,000 | New | +$7.77M | 0.89 | |
| Td Asset Management Inc | $7.05M | 0.48 | 285,806 | +124.55% | +$3.91M | 0.01 | |
| Ameriprise Financial | $6.51M | 0.44 | 263,869 | New | +$6.51M | <0.01 | |
| PRIMECAP Management Co | $5.26M | 0.36 | 213,000 | New | +$5.26M | <0.01 | |
| State Street | $4.95M | 0.34 | 200,691 | +556.05% | +$4.2M | <0.0001 | |
| Jane Street Capital | $4.88M | 0.33 | 197,767 | +91.13% | +$2.33M | 0.01 | |
| Handelsbanken | $4.57M | 0.31 | 185,000 | New | +$4.57M | 0.02 | |
| Balyasny Asset Management Llc | $3.81M | 0.26 | 154,488 | +439.24% | +$3.11M | 0.01 | |
| Morgan Stanley | $3.69M | 0.25 | 149,397 | +1,129.1% | +$3.39M | <0.0001 | |
| Alpine Global Management, LLC | $3.51M | 0.24 | 142,297 | -26.02% | -$1.23M | 0.23 | |
| Northern Trust | $3.34M | 0.23 | 135,488 | +35.18% | +$870,216.84 | <0.01 | |
| Acadian Asset Management | $3.29M | 0.22 | 133,438 | +602.12% | +$2.82M | 0.01 | |
| Monashee Investment Management LLC | $3.27M | 0.22 | 132,500 | New | +$3.27M | 0.28 | |
| Eam Investors | $3.16M | 0.21 | 127,980 | New | +$3.16M | 0.5 | |
| Cetera Advisor Networks LLC | $3.04M | 0.21 | 123,098 | New | +$3.04M | 0.02 | |
| Squarepoint Ops LLC | $2.96M | 0.2 | 119,772 | New | +$2.96M | 0.01 | |
| The Manufacturers Life Insurance Company | $2.71M | 0.18 | 109,686 | +104.08% | +$1.38M | <0.01 | |
| Laurion Capital Management LP | $2.54M | 0.17 | 102,954 | 0% | +$0 | 0.07 | |
| Cerity Partners | $1.96M | 0.13 | 79,223 | +29.14% | +$441,204.22 | 0.01 | |
| J. Goldman & Company | $1.93M | 0.13 | 78,207 | New | +$1.93M | 0.09 | |
| Zimmer Partners Lp | $1.85M | 0.13 | 75,000 | New | +$1.85M | 0.04 | |
| Cubist Systematic Strategies | $1.81M | 0.12 | 73,538 | +617.72% | +$1.56M | 0.02 | |
| Swiss National Bank | $1.76M | 0.12 | 71,400 | New | +$1.76M | <0.01 | |
| Hrt Financial Llc | $1.71M | 0.12 | 69,305 | New | +$1.71M | 0.01 | |
| Wellington Management Company | $1.35M | 0.09 | 54,749 | New | +$1.35M | <0.0001 | |
| Renaissance Technologies | $1.12M | 0.08 | 45,518 | -62.54% | -$1.87M | <0.01 |